THX, yeah, all is well, just patiently waiting for the report, nothing much really to weigh-in on, been here the whole time :)
I suppose it could all get really exciting if we get mediocre survival but excellent secondary or something like that.
The secondary measures topic could be interesting, quality of life is a thing of its own right.
If the secondary is great but primary not so great I'd wait for a bunch of bail outs and then go back in because it will likely still go to market.